UB neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication ...

Although overprescribing can be an issue, doctors warn that overregulating ketamine could reduce access ...

Published in September in Molecular Psychiatry, the UB discovery will also help scientists identify how depression originates in the brain and will stimulate research into using ketamine and ...

Published in September in Molecular Psychiatry, the UB discovery will also help scientists identify how depression originates in the brain, and will stimulate research into using ketamine and ketamine ...

The bottom line: as of now, at least, ketamine is not FDA-approved to treat depression or other mental ... an alternative to older conventional drugs. Yes, ketamine does offer "an alternative." ...

Psychedelics like psilocybin, MDMA, and ketamine are emerging as promising therapeutic tools for mental health issues. Here's ...

Kabir Nigam [Opens in a new window], Evidence indicates that ketamine is highly effective, has a lower side effect profile and is better tolerated compared to many augmentation strategies for ...

A mid-stage trial of oral ketamine tablets has shown promising results in treatment-resistant depression (TRD), setting up a phase 3 programme and a possible challenge to Johnson & Johnson’s ...

Jamie Boland switched from cocaine to ketamine as he thought it was ‘less harmful’ but died from sepsis owing to drug’s long-term effects ...